| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/24/2015 | US8962805 Anti IL-6R polypeptides and compositions thereof |
| 02/24/2015 | US8962804 Meditopes and meditope-binding antibodies and uses thereof |
| 02/24/2015 | US8962803 Antibodies against the RGM A protein and uses thereof |
| 02/24/2015 | US8962801 Neisseria porin proteins |
| 02/24/2015 | US8962560 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases |
| 02/24/2015 | US8962545 Enzyme treatment of foodstuffs for celiac sprue |
| 02/24/2015 | US8962312 Production host cell lines |
| 02/24/2015 | US8962290 Enhanced animal cell growth using ultrasound |
| 02/24/2015 | US8962278 Compositions and methods for production of immunoglobulins |
| 02/24/2015 | US8962275 Anti-α5β1 antibodies and uses thereof |
| 02/24/2015 | US8962274 Methods for selecting eukaryotic cells expressing a heterologous protein |
| 02/24/2015 | US8962262 Method of protein extraction from cells |
| 02/24/2015 | US8962257 Methods for diagnosing heart failure and other cardiac diseases |
| 02/24/2015 | US8962010 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/24/2015 | US8961992 Epsigam fusion protein |
| 02/24/2015 | US8961991 Anti-CD40 targeted fusion proteins |
| 02/24/2015 | US8961986 Peptide composition |
| 02/24/2015 | US8961981 Targeting the neuromuscular junction for treatment |
| 02/24/2015 | US8961980 Monoclonal antibodies for treatment of cancer |
| 02/24/2015 | US8961978 Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses |
| 02/24/2015 | US8961976 Anti-CD154 antibodies |
| 02/24/2015 | US8961974 Multiple-variable dose regimen for treating TNFα-related disorders |
| 02/24/2015 | US8961973 Multiple-variable dose regimen for treating TNFα-related disorders |
| 02/24/2015 | US8961972 Anti-N3pGlu amyloid beta peptide antibodies and uses thereof |
| 02/24/2015 | US8961971 Bispecific T-cell activator antibody |
| 02/24/2015 | US8961970 Combination therapy |
| 02/24/2015 | US8961969 Antagonist antibodies against EphB3 |
| 02/24/2015 | US8961968 Human monoclonal antibodies against CD25 |
| 02/24/2015 | US8961967 Antibody Fc mutants with ablated effector functions |
| 02/24/2015 | US8961966 Antibodies against ERBB3 and uses thereof |
| 02/24/2015 | US8961964 High concentration antibody and protein formulations |
| 02/24/2015 | US8961960 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 02/24/2015 | US8961957 Therapy and method for intratumorally introducing cytotoxic T lymphocyte and/or NKT cell with anti-TNF and/or anti-IL-10 |
| 02/24/2015 | CA2758252C Dkk-1 antibodies |
| 02/24/2015 | CA2708065C Therapeutic agent for pruritus |
| 02/24/2015 | CA2689024C High sensitivity immunoassays and kits for the determination of peptidesand proteins of biological interest |
| 02/24/2015 | CA2663537C Il-17 receptor a antigen binding proteins |
| 02/24/2015 | CA2594233C Monoclonal antibodies against angiopoietin-like protein 4 (angptl4 ) |
| 02/24/2015 | CA2573430C Anti-perp antibody |
| 02/24/2015 | CA2570823C Interferon alpha receptor 1 antibodies and their uses |
| 02/24/2015 | CA2489467C Humanized monoclonal antibody hpam4 |
| 02/24/2015 | CA2447695C Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/19/2015 | WO2015023972A1 Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant |
| 02/19/2015 | WO2015023851A1 Antibodies against frizzled proteins and methods of use thereof |
| 02/19/2015 | WO2015023752A1 Antibodies to plasminogen activator inhibitor-1 (pai-1) and uses thereof |
| 02/19/2015 | WO2015023508A2 Methods for improving asthma symptoms using benralizumab |
| 02/19/2015 | WO2015023507A2 Methods for increasing forced expiratory volume in asthmatics using benralizumab |
| 02/19/2015 | WO2015022658A2 Methods of treating sporadic inclusion body myositis |
| 02/19/2015 | WO2015022656A1 Methods of treating generalized pustular psoriasis (gpp) using il-17 antagonists |
| 02/19/2015 | WO2015022077A1 Novel anti-fc-gamma receptor iib antibodies and uses thereof |
| 02/19/2015 | WO2015022076A1 Novel anti-fcyriib igg-type antibody |
| 02/19/2015 | WO2015021871A1 Antibody specifically binding to glp-1r and fusion protein thereof with glp-1 |
| 02/19/2015 | US20150051380 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 02/19/2015 | US20150051379 Method for treating synovial sarcoma |
| 02/19/2015 | US20150051378 Drg11-responsive (dragon) gene family |
| 02/19/2015 | US20150051377 Drg11-responsive (dragon) gene family |
| 02/19/2015 | US20150051266 Chimeric antigen receptors targeting b-cell maturation antigen |
| 02/19/2015 | US20150051093 Reagents And Methods for Detecting Protein Lysine 3-Hydroxybutyrylation |
| 02/19/2015 | US20150050715 Stably Tethered Structures of Defined Compositions with Multiple Functions or Binding Specificities |
| 02/19/2015 | US20150050693 Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| 02/19/2015 | US20150050669 Method and kit for isolating target cell |
| 02/19/2015 | US20150050640 Novel interferon-lambda4 (ifnl4) protein, related nucleic acid molecules, and uses thereof |
| 02/19/2015 | US20150050349 Systems and methods for particle radiation enhanced delivery of therapy |
| 02/19/2015 | US20150050308 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/19/2015 | US20150050293 Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome |
| 02/19/2015 | US20150050291 Detection and modulation of rheumatoid arthritis |
| 02/19/2015 | US20150050290 Method and Pharmaceutical Composition for use in the Treatment or the Prevention of Aneurysm |
| 02/19/2015 | US20150050288 Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 |
| 02/19/2015 | US20150050287 Anti-cxcl13 antibodies and methods of using the same |
| 02/19/2015 | US20150050286 Anti-ngf antibodies and methods using same |
| 02/19/2015 | US20150050284 Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices |
| 02/19/2015 | US20150050283 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/19/2015 | US20150050282 GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X |
| 02/19/2015 | US20150050281 Methods of treating a tauopathy |
| 02/19/2015 | US20150050280 Soluble human m-csf receptor and uses thereof |
| 02/19/2015 | US20150050279 B-cell receptor complex binding proteins containing t-cell epitopes |
| 02/19/2015 | US20150050278 Soluble engineered monomeric fc |
| 02/19/2015 | US20150050276 High Affinity Antibodies That Neutralize Staphylococcus Enterotoxin B |
| 02/19/2015 | US20150050275 Purification of anti-c-met antibodies |
| 02/19/2015 | US20150050273 Afucosylated anti-fgfr2iiib antibodies |
| 02/19/2015 | US20150050271 Jcv neutralizing antibodies |
| 02/19/2015 | US20150050270 Antibodies to bradykinin b1 receptor ligands |
| 02/19/2015 | US20150050269 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
| 02/19/2015 | US20150050268 Prolonged inhibition of interleukin-6 mediated signaling |
| 02/19/2015 | US20150050267 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 02/19/2015 | US20150050266 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 02/19/2015 | US20150050265 Anti-mcpip therapies for ocular neovascularization |
| 02/19/2015 | US20150050240 Treatment of fibrosis |
| 02/19/2015 | US20150050238 Treatment of osteoarthritis and pain |
| 02/19/2015 | US20150050216 Uses and Compositions for Treatment of Psoriasis |
| 02/19/2015 | US20150050215 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 02/18/2015 | EP2837939A1 Method for the detection of H.pylori infection |
| 02/18/2015 | EP2837685A1 Anti-fgfr2 antibody |
| 02/18/2015 | EP2837680A1 Mammalian cell culture |
| 02/18/2015 | EP2837637A1 Novel anti-FcyRIIB IgG-type antibody |
| 02/18/2015 | EP2837388A1 Compositions and methods for antibodies targeting complement protein C5 |
| 02/18/2015 | EP2837387A1 Anticancer agent |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836843A2 Rapid test for cellular fibronectin |
| 02/18/2015 | EP2836840A1 Detection of platelet-derived shed cd31 |